XSWXSKAN
Market cap1.89bUSD
Dec 20, Last price
75.20CHF
1D
0.40%
1Q
-6.47%
IPO
-14.06%
Name
SKAN Group AG
Chart & Performance
Profile
SKAN Group AG provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions (E&S) and Services and Consumables (S&C). The E&S segment offers mission-critical solutions for the pharmaceutical production, including isolators, integrated automated systems, and aseptic filling systems and solutions, as well as laboratory and cleanroom equipment. The S&C segment provides life cycle support and ready-to-use consumables, as well as customer- specific and digital solutions. The company was formerly known as BV Holding AG and changed its name to SKAN Group AG in October 2021. SKAN Group AG was founded in 1968 and is headquartered in Allschwil, Switzerland.
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 320,020 15.55% | 276,955 18.22% | 234,265 22.21% | |||||||
Cost of revenue | 268,118 | 107,617 | 92,865 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 51,902 | 169,338 | 141,400 | |||||||
NOPBT Margin | 16.22% | 61.14% | 60.36% | |||||||
Operating Taxes | 4,891 | 3,796 | 3,328 | |||||||
Tax Rate | 9.42% | 2.24% | 2.35% | |||||||
NOPAT | 47,011 | 165,542 | 138,072 | |||||||
Net income | 26,312 38.59% | 18,986 -11.27% | 21,398 84.67% | |||||||
Dividends | (5,621) | (5,396) | (10,617) | |||||||
Dividend yield | 0.31% | 0.38% | 0.95% | |||||||
Proceeds from repurchase of equity | (880) | 73,503 | ||||||||
BB yield | 0.06% | -6.56% | ||||||||
Debt | ||||||||||
Debt current | 870 | 1,608 | 1,095 | |||||||
Long-term debt | 5,804 | 15,514 | 14,609 | |||||||
Deferred revenue | 5,911 | 6,727 | 3,809 | |||||||
Other long-term liabilities | 686 | 589 | 1,387 | |||||||
Net debt | (81,628) | (96,111) | (116,753) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 8,700 | 61,483 | 10,317 | |||||||
CAPEX | (35,298) | (28,865) | (42,607) | |||||||
Cash from investing activities | (17,346) | (76,418) | (11,017) | |||||||
Cash from financing activities | (15,801) | (4,846) | 67,484 | |||||||
FCF | 28,151 | 150,823 | (53,355) | |||||||
Balance | ||||||||||
Cash | 85,122 | 110,982 | 131,539 | |||||||
Long term investments | 3,180 | 2,251 | 918 | |||||||
Excess cash | 72,301 | 99,385 | 120,744 | |||||||
Stockholders' equity | 59,079 | 165,595 | 174,006 | |||||||
Invested Capital | 130,368 | 89,430 | 72,635 | |||||||
ROIC | 42.78% | 204.29% | 277.85% | |||||||
ROCE | 26.84% | 88.33% | 72.41% | |||||||
EV | ||||||||||
Common stock shares outstanding | 22,484 | 22,484 | 12,644 | |||||||
Price | 80.80 28.25% | 63.00 -28.89% | 88.60 | |||||||
Market cap | 1,816,669 28.25% | 1,416,462 26.45% | 1,120,220 | |||||||
EV | 1,742,170 | 1,328,648 | 1,017,728 | |||||||
EBITDA | 64,296 | 180,030 | 149,027 | |||||||
EV/EBITDA | 27.10 | 7.38 | 6.83 | |||||||
Interest | 464 | 132 | ||||||||
Interest/NOPBT | 0.27% | 0.09% |